Siemens Healthineers waxay heleen oggolaanshaha isticmaalka degdega ah ee FDA ee baaritaanka ka hortagga SARS-CoV-2

New York-Usbuucii hore, Maamulka Cuntada iyo Dawooyinka ayaa Siemens Healthineers siisay ogolaanshaha isticmaalka degdega ah ee Advia Centaur SARS-CoV-2 IgG ama sCOVG.
Chemiluminescence immunoassay waxaa loogu talagalay in lagu ogaado tayada iyo nus-tirada ee immunoglobulin G ama IgG ee ka dhanka ah SARS-CoV-2 ee serum iyo balasmaha.Tijaabadu waxay ku socotaa Siemens' Advia Centaur XP, Advia Centaur XPT iyo Advia Centaur CP nidaamka difaaca jirka.
Marka loo eego FDA, baaritaankan waxaa isticmaali kara shaybaar kasta oo CLIA ay aqoonsan tahay si loo sameeyo baaritaanno dhexdhexaad ah ama aad u adag.
Bishii Maarso ee sanadkan, SARS-CoV-2 IgG immunoassay ee ay maamusho Siemens AG, oo xarunteedu tahay Erlangen, Jarmalka, falanqeeyeheeda Atellica IM, ayaa EUA ka heshay FDA.
Qaanuunka Arrimaha Khaaska ah.Shuruudaha iyo shuruudaha.Xuquuqda daabacaadda © 2021 GenomeWeb, waa qayb ganacsi oo Crain Communications ah.xuquuqda oo dhan way xifdisan yihiin.